Publications

PEER-REVIEWED PUBLICATIONS (IN CHRONOLOGICAL ORDER).

Total publication: 179 (145+34) (including 34 Book Chapters)

 Total Patents: 7; USA Granted:5; Indian Granted:1; Pending (India/PCT):1

Research articles published in journal: 110

Research articles published in conferences: 8

Number of Review articles: 11

Number of Editorial/Commentary Article: 16 (14+2)

Number of Published Book Chapters (in Elsevier/Wiley/Springer Nature/CRC etc.): 34

Co-Edited book on “Biogenic Nanoparticles for Cancer Theranostics” (Elsevier 2021)

Co-Edited Special issue on “Biomedical Materials Research in India” in Biomedical Materials (IOP Publisher)

Co-Edited Special issue on “Advances in Nanomedicine for Cancer Theranostics” in Biomedical Materials (IOP Publisher)

 Google Citations:10566 & h index= 57, i-index = 122 in Google citations, as on August- 2023].  

Average Impact Factor of all publications (ISI 2020):              > 6

Selected Publications:

1. Nagchowdhury P, Haque S, Patra U, Londhe S, Banerjee R & Patra CR*. Investigation for the pro-angiogenic properties of eggshell-derived nanoparticles. Biomedical Materials, (Online May 14, 2025).

2. Patel A, Londhe S, Tripathy S, Nagchowdhury P, & Patra CR* . Folic acid encapsulated silver nitroprusside nanoparticles for targeted therapy in ovarian cancer, Biomedical Materials, 20(4), 045007

3. Mandarada AP, Roy A, Misra S, Patra CR* & Mutheneni SR*. Upregulation of NOX (NADPH Oxidase 2) and Activation of the PI3K/Akt/MAPK Signaling Pathway in the Pro-Angiogenic and Wound Healing properties induced by Mycosynthesized Iron-Oxide Nanoparticles. BioNanoScience, 15(3), 1-27. 

4. Julappagari M, Haque S, Tripathy S, Londhe S, Patel A, Banerjee R* & Patra CR* Gold nanoparticles-based Targeted Delivery of Rapamycin and Olaparib to breast cancer: An in vitro and in vivo Approach. Bioorganic Chemistry, 158,108322,2025

5. Londhe S, Tripathy S, Saha S, Patel A, Chandra Y & Patra CR* Therapeutic potential of silver nitroprusside nanoparticles for melanoma. ACS Applied Bio Materials 7(8), 5057(August 08, 2024)

6. Tripathy S, Londhe S, Patel A, Saha S, Chandra Y & Patra CR* Copper nitroprusside analogue nanoparticles against melanoma: Detailed in vitro and in vivo investigation. Nanoscale 16, 13580(June 17, 2024)

7. Tella JO, Adekoya JA, Ajanaku KO, Banerjee R, Patra CR, Pavuluri S, Sreedhar B. Amino-functionalised mesoporous silica nanoparticles for the delivery of isoniazid and its metal complexes. Materials Chemistry and Physics, 326,129820 (Aug. 2024)

8. Patel A, Londhe S, Saha S & Patra CR* Metal Nanoparticles for ovarian cancer therapy. Current Indian Science (In Press)

9. Basu Thakur P, Roy A, Ghosh S, Vijay V, Sinha D, Radhakrishnana M, Kumar A,  Patra CR* and S. Chakravarty* Pro-angiogenic Terbium Hydroxide Nanorods Improve Critical Limb Ischemia in part by Amelioration of Ischemia-Induced Endothelial Injury. ACS Appl. Bio Mater 7(7) 4389 (Online June7, 2024)

10. Tripathy S, Haque S, Londhe S, Das S, Norbert CC, Chandra Y, Sredhar B and Patra CR* ROS mediated Cu[Fe(CN) 5 NO] nanoparticles for triple negative breast cancer: A detailed study in preclinical mouse model. Biomaterials Advances.

11. Haque S, Tripathy S, Chandra Y, Kathirvel M and Patra CR* Toxicity Study of Pro-Angiogenic Casein Manganese Oxide Nanoparticles: An In Vitro and In Vivo Approach. Nanotoxicology.17(10), 604-627(Dec. 2023).

12. Londhe S, Saha S and Patra CR* Biomedical applications of zinc sulfide nanoparticles. Prayogik Rasayan

13.  Barui AK, Bollu VS, Londhe S, Deshpande S, Das S, Nethi S, Alabbasi MMA, Kuncha M, Jerald MK, Sistla R, Misra S, Patra CR* Toxicological Evaluation of Therapeutically Active Zinc Oxide Nanoflowers in Pre-clinical Mouse Model. NanoImpact, Volume 31, July 2023, 100479.

14. Haque S, Kotcherlakota R, Bhamidipati P, Muralidharan K, Sreedhar B, Amanchy R, Patra CR*  Smartly Engineered Casein Manganese Oxide Nanobiomaterials and its Potential Therapeutic Angiogenesis Applications for Wound Healing and Limb Ischemia. Advanced Therapeutics,  Volume 6, Issue 9 September 2023, 2300142.

15. Basuthakur P, Roy A, Patra CR* and Chakravarty S* Therapeutic Potentials of Terbium Hydroxide Nanorod for Amelioration of Hypoxia-Reperfusion Injury in Cardiomyocytes. Biomaterials Advances. Volume 153, October 2023, 213531. 

16. Londhe S, Haque S, Tripathy S, Bojja S, Patra CR*. Silver Nitroprusside Nanoparticles for Breast Cancer Therapy: In vitro and In vivo Approach. Nanoscale, 2023,15, 10017-10032. 

17. Das S, Tripathy S, Sreedhar B, Mukherjee S* & Patra CR* . Design of Lysozyme-templated Biocompatible Fluorescent Nanocomposites and Their Potential Applications for Cell Imaging, Hydrogen Peroxide Sensing and Cancer Therapy. Advanced Therapeutics, ISI IF # 5.003 

18. Mandal BB* & Patra CR*, Kundu SC*. Biomedical Materials research in India. Biomedical Materials, ISI IF # 4.103 

19. Choudante PC, Nethi SK, Díaz-García D, Prashar S, Misra S*, Gómez-Ruiz S* & Patra CR*. Tin-loaded mesoporous silica nanoparticles: Antineoplastic properties and genotoxicity assessment. Biomaterials Advances, 137, 212819 (June 2022). ISI IF #7.328.

20. Haque S, Norbert CC, Acharyya R, Mukherjee S, Kathirvel M, Patra CR*. Biosynthesized Silver Nanoparticles for Cancer Therapy and In Vivo Bioimaging. Cancers 13 (23), 6114 (2021). ISI IF #6.639.

21. Mukherjee S*, Bollu VS, Roy A, Nethi SK, Madhusudana K, Sistla RK and Patra CR*.  Acute toxicity, bio-distribution and pharmacokinetics studies of pegylated platinum nanoparticles in mouse model.  Advanced NanoBiomed Research, 1, 7, 2000082 (Online publication May 13, 2021)

22. Nethi SK, Barui A, Jhelum P, Basuthakur P, Bollu VS, Reddy BR, Chakravarty S & Patra CR*. Europium hydroxide nanorods (EHN) mitigate hind limb ischemia in Wistar rats. Advanced Therapeutics, 4, 6, 2100016 (April 8, 2021).

23. Barui A*, NethiSK, Basuthakur P, Jhelum P, Bollu VS, Reddy BR, Chakravarty S* & Patra CR*. Therapeutic angiogenesis using zinc oxide nanoflowers for the treatment of hind limb ischemia in rat model.  Biomedical Materials, 16, 044103 (Online March 26, 2021). ISI IF #3.715.

24. Rao BR, Kumar R, Haque S, Kumar JM, Rao TN, Kothapalli, RVSN & Patra CR*. Ag2[Fe(CN)5NO]-Fabricated Hydrophobic Cotton as a Potential Wound Healing Dressing: An In Vivo Approach. ACS Appl. Mater. Interfaces, 2021, 13, 9, 10689–10704. Online Publication February 23-2021. ISI IF #9.229.

25. Roy A, Nethi SK*, Suganya N, Raval M, Chatterjee S and and Patra CR*. Attenuation of cadmium-induced vascular toxicity by pro-angiogenic nanorods. Mater. Sci. Engg. C, (Online May 21-2020). ISI IF #7.328

26. Das S, Roy A, Barui AK, Amontader A, Kuncha M, Sistla R, Sreedhar B and Patra CR*. Anti-angiogenic vanadium pentoxide nanoparticles for the treatment of melanoma and their in vivo toxicity study. Nanoscale, 12, 7604-7621 (March 13, 2020). ISI IF #7.79.

27. Barui AK, Jhelum P, Nethi SK, Das T,  Bhattacharya D, Vinothkumar B, Karri S, Chakravarty S* & Patra CR*. Potential Therapeutic Application of Zinc Oxide Nanoflowers in Cerebral Ischemia Rat Model Through Neuritogenic and Neuroprotective Properties. Bioconjugate Chemistry, 31, 895-906 (2020) (Publication date: February 12, 2020). ISI IF #4.774.

28. Mukherjee S, Kotcherlakota R, Haque S, Das S, Nuthi S, Bhattacharya D, Madhusudana K, Chakravarty S, Sistla R & Patra CR*. Prussian Blue Analogue Nanoparticles (SPBANPs): Rationally Designed Advanced Nanomedicine for Multifunctional Biomedical Applications. ACS Biomater. Sci. Eng. 6, 690-704 (2020) (Publication date: December 11, 2019). ISI IF #4.749.

29. Barui AK, Nethi SK, Haque S, Basuthakur P & Patra CR.* Recent development of metal nanoparticles for angiogenesis study and their therapeutic applications. ACS Appl. Bio Mater. 12, 5492-5511 (2019) Online Oct. 18, 2019).

30. Mukherjee S, Kotcherlakota R, Bhattacharya D, Jerald MK, Chakravarty S and Patra CR.* Improved delivery of doxorubicin using rationally designed PEGylated platinum nanoparticles for the treatment of melanoma. Mater. Sci. Engg. C. 108, 110375 (March 2020). ISI IF #7.328.

31. Bollu VS, Bathini T, Barui AK, Roy A, Ragi NC, Maloth S, Sripadi P, Sreedhar B*, Nagababu P* & Patra CR*. Design of DNA-intercalators based copper (II) complexes, investigation of their potential anti-cancer activity and sub-chronic toxicity. Mater. Sci. Engg. C. 105, 110079 (2019) (Published on August 14, 2019). ISI IF #7.328.

32. Kotcherlakota R, Nimushakavi S, Roy A, Yadavalli HC, Mukherjee S, Haque S & Patra CR*. Biosynthesized gold nanoparticles: In vivo study of near infra-red fluorescence (NIR) based bio-imaging and cell labeling applications. ACS Biomater. Sci. Eng. 2019, 5, 10, 5439-5452. (Published on August 14, 2019). ISI IF #4.749.

33.  Kotcherlakota R, Vydiam K, Jeyalakshmi SD, Mukherjee S, Roy A, Kuncha M, Rao TN, Sistla R, Gopal V* &  Patra CR*. Restoration of p53 function in ovarian cancer mediated by gold nanoparticles based EGFR targeted gene delivery system. ACS Biomater. Sci. Eng. 2019, 5, 7, 3631-3644 (Published on June 5 2019). ISI IF #4.749

34. Meka RR, Mukherjee S, Patra CR* & Chaudhuri A*. Shikimoyl-ligand decorated gold nanoparticles induce anti-tumor immune response in dendritic cell-based DNA vaccination. Nanoscale, 11, 7931-7943 (March 27, 2019). ISI IF #7.79.

35. Vemuri SK, Nethi SK, Banala RR, Subbaiah GPV*, Gurava Reddy AV, Patra CR*. Europium hydroxide nanorods (EHNs) ameliorate isoproterenol-induced myocardial infarction: An in vitro and in vivo investigation. ACS Applied Bio Material, 2 (3), pp 1078–1087 (February 2019).

36. Gulla SK, Rao BR,  Moku GK,  Jinka S,  Nimmu NV,  Khalid S,  Patra CR* and  Chaudhuri A*. In vivo targeting of  DNA vaccines to dendritic cells using functionalized gold nanoparticles. Biomaterials Science, 7, 773-788 (2019), (First published on Dec. 2018). ISI IF #6.843.

37. Rao BR, Kotcherlakota R, Nethi SK, Puvvada N, Bojja S, Chaudhuri A*, Patra CR*. Ag2[Fe(CN)5NO] nanoparticles exhibit anti-bacterial activity and wound healing properties. ACS Biomater. Sci. & Eng. 4(9), 3434-3449 (Aug.2018). ISI IF #4.749.

38. Gulla SK, Kotcherlakota R, Nimushakavi S, Nimmu NV, Khalid S, Patra CR* & Chaudhuri A*. Au-CGKRK nanoconjugates for combating cancer through T cell driven therapeutic RNA interference. ACS Omega, 3(8), 8663-8676 (Aug. 2018). ISI IF #3.512.

39. Nethi S, Barui, AK; Bollu BS; Bonda R and Patra CR*. Pro-angiogenic properties of terbium hydroxide nanorods: Molecular mechanisms and therapeutic applications in wound healing. ACS Biomaterials Science & Engineering, 3, 12, 3635-3645, Nov. 2017. ISI IF #4.749.

40. Nethi SK, Nanda HS*, Steele TWJ and Patra CR*. Functionalized nanoceria exhibit improved angiogenic properties.  J. Mater. Chem. B. 5, 9371-9383 (Nov.2017). ISI IF #6.331.

41. Chowdhury S, Mukherjee S, Das S, Patra CR* & Iyer PK*. Multifunctional (3-in-1) cancer theranostics applications of hydroxyquinoline appended polyfluorene nanoparticles. Chemical Science, 8, 7566-7575 (Aug. 2017). ISI IF #9.825.

42. Kumar R, Das S , Mukherjee S, Bhosale RS*, Patra CR* and Narayan R*. Novel Tetraphenylethylene Diol Amphiphile with Aggregation-Induced Emission: Self-assembly, Cell imaging and Tagging Property. Mater. Sci. Engg. C. 81, 580-587 (Dec.2017). ISI IF #7.328.

43. Kotcherlakota R, Srinivasab D, Mukherjee S, Haroon M, Dar G, Venkatraman U, Patra CR* and Gopal V*. Engineered fusion protein-loaded gold nanocarriers for targeted co-delivery of doxorubicin and erbB2-siRNA in human epidermal growth factor receptor-2+ ovarian cancer. J. Mater. Chem.B. 5, 7082-7098 (Aug. 2017). ISI IF #6.331.

44. Barui AK, Nethi SK & Patra CR*. Investigation of the role of nitric oxide driven angiogenesis by zinc oxide nanoflowers. J. Mater. Chem.B 5, 3391-3403 (April 2017). ISI IF #6.331.

45.  Augustine R*, Nethi SK, Kalarikkal N, Thomas S, Patra CR*. Electrospun polycaprolactone (PCL) scaffolds embedded with europium hydroxide nanorods (EHNs) with enhanced vascularization and cell proliferation for tissue engineering applications. J. Mater. Chem. B 5, 4660-4672 (May 2017). ISI IF #6.331.

46. Nethi SK, Aparna N, Rico-Ollerb B, Rodríguez-Diéguezc A, Gómez-Ruizb S*, Patra CR*. Design, synthesis and characterization of doped-titanium oxide nanomaterials with environmental and angiogenic application. Science of the Total Environment, 599-600, 1263-1274 (Dec.2017). ISI IF #7.963.

47. Muthuraj B, Mukherjee S, Patra CR* and Iyer PK*. Amplified Fluorescence from Polyfluorene Nanoparticles with Dual State Emission and Aggregation Caused Red Shifted Emission for Live Cell Imaging and Cancer Theranostics. ACS Appl. Mater. Interfaces, 8 (47), 32220-32229(2016). ISI IF #9.229.

48. Gaddam RR, Mukherjee S, Punugupati N, Vasudevan D, Patra CR, Narayan R, Raju KVSN*. Facile synthesis of Carbon dot and residual carbon nanobeads: Implications for ion sensing, medicinal and biological applications. Mater. Sci. Eng. C. 73, 643-652 (April 2017) ISI IF #7.328.

49. Bollu VS, Barui AK, Mondal SK, Prashar S, Fajardo M, Briones D, Rodríguez-Diéguez A, Patra CR* and Gómez-Ruiz S*. Curcumin-loaded silica-based  mesoporous materials: Synthesis, characterization and cytotoxic properties against cancer cells. Mater. Sci. Eng. C, 63, 393-410(2016). ISI IF #7.328.

50. Raj M, Mukherjee S, Roychowdhury S, Patra CR*, Iyer PK*. An Efficient Strategy to Assemble Water Soluble Histidine-Perylene Diimide and Graphene Oxide for the Detection of PPi in Physiological conditions and in vitro. Biosens Bioelectron, 89(pt.1),636-644 (2017) Highlighted in ‘Atlas of Science’. ISI IF #10.618.

51. Kotcherlakota R, Barui AK, Prashar S,  Fajardo M, Briones D, Rodríguez-Diéguez A, Patra CR*, Gómez-Ruiz S*. Curcumin loaded mesoporous silica: An effective drug delivery system for cancer treatment. Biomaterials Science 4, 448-459 (2015). ISI IF #6.843.

52. Wei P, Jin P-P, Barui AK, Hu Y, Zhang L, Zhang J-Q, Shi S-S, Zhang H-R, Lin J, Zhou W, Zhang Y-Z, Patra CR* & Wen LP*. Differential ERK activation during autophagy induced by europium hydroxide nanorods and trehalose: maximum clearance of huntingtin aggregates through combined treatment. Biomaterials, 73, 160-174 (2015). ISI IF #12.479.

53. Bollu VS, Nethi SK, Dasari RK, Rao NSS, Misra S* and Patra CR*. Evaluation of in vivo cytogenetic toxicity of europium hydroxide nanorods (EHNs) in male & female Swiss albino mice. Nanotoxicology, 10(4), 413-25 (2016). ISI IF #5.913.

54. Nagababu P*, Barui AK, Thulasiram B, Devi CS, Satyanarayana S, Patra CR*, Sreedhar B*. Anti-angiogenic activity of mononuclear copper(II) polypyridyl complexes for the treatment of cancers. J. Med. Chem. 58(13), 5226-5241 (2015). ISI IF #7.446.

55. Mukherjee S, Sreeram P, Barui AK, Nethi SK, Veeriah V, Chatterjee S, Suresh KI, Patra CR*. Graphene oxides show angiogenic properties. Adv. Healthcare Mater. 4 (11), 1722-32 (2015). ISI IF #9.933

56. Nethi SK, Veeriah V, Barui AK, Rajendran S, Mattapally S., Misra S, Chatterjee S* and Patra CR*.-Investigation of molecular mechanisms and regulatory pathways of pro-angiogenic nanorods. Nanoscale, 7, 9760-9770 (2015). ISI IF #7.79.

57. Mukherjee S, Rao BR, Sreedhar B, Paik P and Patra CR*.-Copper Prussian blue analogue: Investigation for multifunctional activities in biomedical applications. Chem.Comm. 51(34), 7325-7328 (2015).Highlighted in ‘’Nature India”. ISI IF #6.222.

58. Mukherjee S, Sau S, Madhuri D, Bollu VS, Madhusudana M, Sreedhar B, Banerjee R* and Patra CR*.-Green synthesis and Characterization of monodispersed gold nanoparticles:  Toxicity study, delivery of doxorubicin & its bio-distribution in mice model. J.Biomed. Nanotechnol. 11, 1-17 (2015). ISI IF #4.099

59.  Patra S, Mukherjee S, Barui AK, Ganguly A, Sreedhar B and Patra CR*.Green synthesis, characterization of gold and silver nanoparticles and their potential application for cancer therapeutics. Mater. Sci. Eng. C. 53, 298-309 (2015). ISI IF #7.328

60. Mukherjee S, Dasari M, Priyamvada S, Kotcherlakota R, Bollu VS, Patra CR*. Biosynthesized gold nanoconjugates induces the inhibition of cancer cells proliferation through induction of oxidative stress and their in vivo toxicity study. J. Mater. Chem. B. 3, 3820-3830 (2015). ISI IF #6.331.

61. Nethi SK, Mukherjee S, Veeriah V, Barui AK, Chatterjee S, Patra CR*. Bioconjugated gold nanoparticles accelerate the    growth of new blood vessels through redox signaling. Chem.Comm. 50, 14367-14370(2014) Highlighted in ‘’Nature India”. ISI IF #6.222.

62. Sau S, Agarwalla P, Mukherjee S, Bag I,  Sreedhar B, Pal- Bhadra M, Patra CR*, Banerjee R*.-Cancer Cell-Selective             Promoter Recognition Accompanies Antitumor Effect by Glucocorticoid Receptor-Targeted Gold Nanoparticle. Nanoscale, 6,   6745-6754 (2014). ISI IF #7.79.

63. Mukherjee S, Chowdhury D, Kotcherlakota R, Patra S, Vinothkumar B, Pal Bhadra M, Sreedhar B and Patra CR*. Potential theranostics application of bio-synthesized silver nanoparticles (4-in-1 system).Theranostics 4(3), 316-335 (2014). Highlighted in ‘’Nature India”.ISI IF #11.556.

64. Wei P, Zhang L, Nethi SK, Barui AK, Lin J, Zhou W, Shen Y, Zhang Y, Xu J, Patra CR* & Wen LP*.-Europium hydroxide nanorods accelerate the clearance of mutant huntingtin through autophagy induction.-Biomaterials, 35(3) 899-907 (2014) ISI IF #12.479.

65. Modak A, Barui AK, Patra CR*, Bhaumik A*. A luminescent nanoporous hybrid material based drug delivery system shows excellent theranostics potential for cancer. ChemComm. 49, 7644-7646 (2013). Highlighted in ‘’Nature India”. ISI IF #6.222.

66. Barui AK, Veeriah V, Mukherjee S, Manna J, Patel AK, Patra S, Pal K, Murali S, Rana RK, Chatterjee S, Patra CR*. Zinc oxide nanoflowers make new blood vessels. Nanoscale 4, 7861-7869(2012). Highlighted in ‘’Nature India” and “The Hindu”. ISI IF #7.79.

67. Patil NT* Shinde VS, Thakare MS, Kumar PH, Bangal PR*, Barui AK and Patra CR*.Exploiting Higher Alkynophilicity of Au-Species: Development of Highly Selective Fluorescent Probe for Gold Ions. Chem.Comm. 2012 (48, 11229-11231).Highlighted in CSIR News. ISI IF #6.222.

68. Patra CR, Rupasinghe CN, Bhattacharya S, Wang E, Spaller MR, Mukhopadhyay D. Chemically-Modified Peptides Targeting the PDZ Domain of GIPC as a Therapeutic Approach for Cancer. ACS Chem. Biol. 7(4), pp 770–779 (2012) ISI IF #5.110.

69. Patra CR*, Kim J-H, Pramanik K, d’Uscio LV, Patra S, Katusic ZS, Ramchandran R, Strano MS, Mukhopadhyay D*. Reactive Oxygen Species Driven Angiogenesis by Inorganic Nanorods. Nano Letters, 11(11), 4932–4938 (2011), ISI IF #11.139.

70. Wang, L#, Lau JS#, Patra CR#, Cao Y, Bhattacharya S, Dutta S, Nandy D, Wang E, Rupasinghe CN, Vohra P, Speller MR, and Mukhopadhyay D.[# First three authors have equal contribution-The RGS-GAIP-interacting protein Controls Breast Cancer Progression. Mol. Cancer Res. 8, 1591-1600, 2010. ISI IF #5.852.

71. Patra CR, Jing Y, Xu Y-H, Bhattacharya R, Mukhopadhyay D, Glockner JF, Wang J-P, Mukherjee P. A core-shell nanomaterial with endogenous therapeutic and diagnostic functions. Cancer Nanotechnology, 1, 13-18 (2010). ISI IF #5.095.

72. Patra CR, Bhattacharya R, Mukherjee P. Fabrication and functional characterization of goldnanoconjugates for potential application in ovarian cancer. J. Mater. Chem. 20 (4), 547-554 (2010).(Latest old IF)-6.626

73. Patra CR*, Abdel Moneim S, Wang E, Dutta S, Eshed M, Mukherjee P,  Patra S, Gedanken A, Shah V, Mukherjee P and Mukhopadhyay D.-In Vivo Toxicity Studies Europium Hydroxide in Mice. Toxicol. Appl. Pharmacol. 240, 88-98(2009).  ISI IF #4.219.

74. Patra C R, Bhattacharya R, Wang E, Katarya A, Lau J S, Dutta S, Muders M, Wang S, Buhro S, Safgren S, Yaszemski M J, Reid J, Ames M, Mukherjee P, Mukhopadhyay D.-Targeted delivery of gemcitabine to pancreatic tumor using cetuximab as a targeting agent. Cancer Res. 68(6), 1970-1978 (March 15, 2008). Highlighted in Discovery’s Edge, Mayo Clinic’s online research magazine. ISI IF #12.701.

75. Patra CR, Bhattacharya R, Patra S, Vlahakis NE, Gabashvili A, Koltypin Y, Gedanken A, Mukherjee P and Mukhopadhyay D.-Proangiogenic properties of europium(III) hydroxide nanorods. Highlighted in ‘Nature Nanotechnology’. BRIC, South Korea, Discovery’s Edge, Mayo Clinic’s online research magazine, Frost & Sullivan. Adv.Mater. 20(4), 753-756(2008). ISI IF #30.849

76. Patra CR, Bhattacharya R, Patra S, Basu S, Mukherjee P and Mukhopadhyay D. Lanthanide Phosphate nanorods used as inorganic fluorescent label in cell biology research. Clin. Chem.53(11)- 2029-2031(2007). ISI IF #8.327

77. Patra CR, Bhattacharya R, Patra S, Basu S, Mukherjee P and Mukhopadhyay D. Inorganic Phosphate Nanorods are a Novel Fluorescent Label in Cell Biology. J. Nanobiotechnolgy, 2006, 4:11. ISI IF #10.435

Selected Editorials:

1.  Saha S, Tripathy S and Patra CR* Neuritogenic Activity of Metal Nanoparticles. Nanomedicine, 19(5), Jan 2024.

2.   Nagchowdhury, P & Patra CR*. Tin-based nanomaterials for biomedical applications. Nanomedicine (in press),                   ISI IF # 6.096

3. Nagchowdhury, P & Patra CR*. Nanotechnology in hair growth: Opportunities and Challenges. Nanomedicine, ISI IF # 6.096

4. Londhe S and Patra CR*. Biomedical applications of europium hydroxide nanorods. Nanomedicine (Online Sept.6,  2021-2021). ISI IF # 6.096

5. Haque S, Tripathy S and Patra CR*. Biomedical applications of silver nitroprusside nanoparticles (Editorial Topic) Nanomedicine (Lond.) 16, 19-1627(2021)(Online July 1-2021) ISI IF # 6.096

6. Haque S & Patra CR*. Biologically synthesized gold nanoparticles as a near-infrared-based bioimaging agent. (Editorial Topic) Nanomedicine 16 (5), 351-354 (Online March 4, 2021). ISI IF # 6.096

7. Haque S & Patra CR*. Nanoparticle-based angiogenesis for the recovery of heavy metal-induced vascular toxicity. (Editorial Topic) Nanomedicine 16 (5), 351-354 (Online February 18, 2021). ISI IF # 6.096

8. Basuthakur P & Patra CR*. Zinc oxide nanoparticles: future therapy for cerebral ischemia (Editorial Topic). Nanomedicine 15, 28 (2729-2732)(Online October 20, 2020). ISI IF # 6.096

9. Roy A & Patra CR*. Vanadium pentoxide nanomaterials and their role in anti-angiogenesis for cancer treatment (Editorial Topic) Nanomedicine 15, 27 (2643-2646) (Online October 20, 2020). ISI IF # 6.096

10. Haque S & Patra CR* Silver Prussian Blue Analogue Nanomedicine for Future Cancer Therapy               (Editorial Topic). Future Oncology (Online Nov 27) 2020.

11. Patra CR.* Prussian blue nanoparticles and its analogues for the application of cancer theranostics.-Nanomedicine 11(6), 569-572 (2016) (Lond.) ISI IF # 6.096

12. Patra CR*, Mukherjee S & Kotcherlakota R.-Biosynthesized
silver
nanoparticle:a step forward for cancer theranostics? Nanomedicine 9(10), 1445-1448 (2014). ISI IF # 6.096

13. Patra CR*, Barui AK. Nanoflowers: a future therapy for cardiac and ischemic disease? Nanomedicine 8 (11) 1735- 1738, 2013. ISI IF # 6.096

Selected Review Articles:

 1. Haque S, Tripathy S and Patra CR*. Manganese based Advanced Nanoparticles for Biomedical Applications: Future       opportunity and Challenges. (DOI:https://doi.org/10.1039/D1NR04964J), Nanoscale (Online Sept.6, 2021-2021). ISI IF #7.79.

2. Nethi SK*, Das S, Patra CR* & Mukherjeee S*. Recent advances in inorganic nanomaterials for wound healing applications. Biomaterials Science (Published on April 24, 2019), 7, 2652-2674. ISI IF #6.843.

3. Kotcherlakota R, Rahaman ST & Patra CR*. Nanomedicine for cancer therapy using Autophagy: An Overview. Curr Top Med. Chem. 18(30):2599-2613. (Dec. 2018).

4. Nethi SK, Barui AK, Mukherjee S & Patra CR*. Engineered nanoparticles for effective redox signaling during angiogenic and anti-angiogenic therapy. Antioxid. Redox Signal 30(5), 786-809 (2019) (First online publication: Aug.24,  2018). ISI IF #8.401.

5. Mukherjee S and Patra CR* -Therapeutic application of anti-angiogenic nanomaterials in cancers. Nanoscale 8, 12444-12470(2016). ISI IF #7.79.

6. C.R. Patra, R. Bhattacharya, D. Mukhopadhyay and P. Mukherjee.-Fabrication of Gold Nanoparticles for targeted therapy in pancreatic cancer. Adv. Drug Deliv. Rev (ADDR), 62, 346-361(2010). ISI IF #15.47.

7. C.R. Patra, R. Bhattacharya, D. Mukhopadhyay and P.Mukherjee-Application of gold   nanoparticles for targeted therapy in cancer. J. Biomed. Nanotechnol. 4, 99-132(2008). ISI IF #4.099.

     Selected book chapters:

1.  Patra CR*. (Invited Book Chapter)-Europium hydroxide nanorods and angiogenic processes” in “Nanomedicine and the Cardiovascular System”. Edited by Ross J. Hunter and Victor R. Preedy, Page. 370-390, July 2011,CRC Press, Science Publishers, Jersey, British Isles Enfield, New Hampshire, USA.

2.  Patra CR*, Mukherjee P, Mukhopadhyay D.(Invited Book Chapter) Application of Lanthanide (Ln= Eu & Tb) nanoparticles in Biology and Medicine. Editors: Brian H. Mitchem and Charles L. Charnham-Clinical Chemistry Research”, Chapter III, Page 99-141, 2009. © 2009 Nova Science Publishers, Inc.

3.  Bhattacharya R, Mukherjee P, Patra CR and Mukhopadhyay D. (Invited Book Chapter) Nanogold in cancer therapy and Diagnosis. Editor: Challa Kumar,Vol. 7, 2006, Wiley publisher, New York. Nanomaterials for Cancer Diagnosis, Vol.7” of series “Nanotechnologies for the Life Sciences”

4.  Kumar R, Ghosh A, Patra CR, Mukherjee P, Sastry M.(Invited Book Chapter). Gold Nanoparticles Formed within Ordered Mesoporous Silica and on Amorphous Silica. Editors: BING ZHOU, SOPHIE HERMANS & GABOR A. Somorjai. Chapter-6, 20004; 1: 111-136. Nanotechnolgy in Catalysis” Published under “Nanostructure Science and Technology Series, Series Editor: David J. Lockwood.

5.  Kulahari H, Pooja D, Shrivastava S, Reddy TS, Barui AK, Patra CR, Naidu VGM, Adams DJ, Sistla R.-Cyclic RGDfK-directed docetaxel nanomicelles for angiogenic tumor targeting. In: Patsenker E. (eds) Integrin Targeting Systems for Tumor Diagnosis and Therapy.  ‘Methods in Pharmacology and Toxicology’.Springer Sciences, Humana Press, New York (205). Online publication on February11, 2016.

6.  Barui Ak, Kotcherlakota R and Patra CR*. (Invited) Medicinal applications of metal nanoparticles. In “Metal Nanoparticles: Synthesis and Applications in Pharmaceutical Sciences”.  Edited by Thota & Crans. Online publication: January 3, 2018.Chapter 5, Page 101-153, John Wiley & Sons,VCH Verlag GmbH & Co. KGaA, Weinheim, Germany. Online December 22, 2017.

7.  Mukherjee S, Nethi SK and Patra CR*. (Invited) ‘Green synthesized gold nanoparticles for future biomedical applications. In ‘Particulate Technology for Delivery of Therapeutics’. Edited by Jana & Jana. Online publication: October 11, 2017-Springer Publisher, Singapore, Page-359-393, Online October 11, 2017.

8.  Barui AK, Kotcherlakota R, Bollu VS, Nethi SK & Patra CR*. Biomedical and Drug Delivery Applications of Functionalized Inorganic Nanomaterials. In: Biopolymer-Based Composite under “Drug Delivery and Biomedical Applications” Edited by Jana and Maiti, Online Publication: January 1, 2017.Woodhead Publisher 2017, Pages 325-379.

9.  Barui AK, Kotcherlakota R, Patra CR*. “Biomedical applications of zinc oxide nanoparticles. In: Inorganic Frameworks as Smart Nanomedicines. Edited by Grumezescu, Online Publication: April 13, 2018.Elsevier @ April, 13, 2018,Chapter 6, Page-239-278 (April 13, 2018).

10.  Mukherjee S, Kotcherlakota R, Rao BR, Patra CR*.  Prussian blue nanoparticles for cancer theranostic. In: Prussian Blue Nanoparticles and Nanocomposites- Synthesis, Devices, and Applications. Edited by Guari-Pan Stanford Publishing (April 18, 2019),Chapter-9, p.243-278.

11.  Kotcherlakota R, Das S & Patra CR*. Therapeutic Applications of Green Synthesized Silver Nanoparticles. In: Green Synthesis, Characterization and Applications of Nanoparticles. Edited by Shukla & Iravani, Elsevier Published (Published January 11-2019), Chapter-16 p. 389-428.

12.  Barui Ak, Das S & Patra CR*. Biomedical applications of green synthesized metal nanoparticles using polysaccharides. In: Functional Polysaccharides for Biomedical Applications. Edited by S. Maiti & S. Jana-Elsevier Publisher, Online publication date: July 11, 2019, Chapter 10 p.329-355.

13.  Das S, Basu Thakur P, Harri A, Bagade M and Patra CR*. Nanomedicine for wound healing: Challenges and Future Perspectives. In: Nanotechnology in Biology and Medicine: Research Advancements & Future Perspectives. Edited by Rauta, Mohanta & Nayak-CRC Publisher, Taylor & Francis Group, Online October 10, 2019,Chapter 9, 17 pages.

14.  Nethi, SK, Bollu VS, Anand P NA & Patra CR*. Rare Earth Based nanoparticles: Biomedical Applications, Pharmacological and Toxicological Significance, In: Nanoparticles in Medicine (Pharmaceutical Nanotechnology). Edited by Shukla-Springer Nature, Singapore (Published),March 7, 2020,p.1-43.

15.  Das S, Pabba M, Dhushyandhun M.E & Patra CR*. Theranostic application of Lysozyme based nanoparticles. In: Nanoparticles in Medicine. Edited by Shukla-Springer Nature Singapore, Online September 1, 2019, p.1-23.

16.  Kotcherlakota R, Das S & Patra CR*. Non-Invasive Imaging Techniques of Metal Nanoparticles and Their Future Diagnostic Applications. In: Medical Imaging Methods: Recent Trends".Edited by AK Shukla-Springer Nature Singapore, p.119-141, Online October 12, 2019.

17.  Barui Ak, Arpita Roy, Das S, Keerti Bhamidipati & Patra CR*. Therapeutic Applications of Graphene Oxides in Angiogenesis and Cancers, In: Nanoparticles and their biomedical applications. Edited by Shukla-Springer Nature Singapore, Online March 7, 2020 p.147-189.

18.  Basu Thakur P, Haque S, Adhikary B & Patra CR*. Nanomedicine for Ischemic Diseases: Recent Development and Future Challenges. In: Nanotechnology in the Life Sciences Series. Edited by Dr. Devarajan Thangadurai, -Springer Nature,(Online Publication July 9, 2020).

19.  Haque S, Celine C and Patra CR. Nanomedicine: Future therapy for Brain Cancers. In: Nano Drug Delivery Strategies for the Treatment of Cancers. Edited by Umesh Gupta-Elsevier (Online Publication September 11, 2020).

20.  Papia Basuthakur & Patra CR. Green synthesized nanoparticles for fluorescence bio-imaging and diagnostic applications. In: Biogenic Nanoparticles for Cancer Theranostics: Micro and Nano Technologies. Edited by Edited by Patra, Ahamed, Ayaz, Khalil, Mukherjee & Ovais-Chapter-8,  p. 153-188, May 2021.

21.  Das S & Patra CR. Green synthesis of iron oxide nanoparticles using plant extracts and its biological application. In: Handbook of Greener Synthesis of Nanomaterials and Compounds. Edited by Dr. Boris Ildusovich Kharisov & Dr. Oxana Vasilievna Kharissova-Elsevier (April 2021) Chapter 6, Vol.2, p. 139-170.

22.  Haque S & Patra CR. Biosynthesized Nanoparticles (Gold, Silver & Platinum): Therapeutic Role in Angiogenesis. In: Comprehensive Analytical Chemistry. Volume 94, 2021, Pages 471-505. Edited by: Sandeep Kumar Verma & Asdhok Kumar Das –Elsevier (August 2021).

23.  Roy A, Basuthakur P & Patra CR. Therapeutic Applications of Noble Metal (Au, Ag, Pt) - Based Nanomedicines for Melanoma. In: Nanomedicine for Cancer Diagnosis and Therapy. Editors: Malik, Arshi, Afaq, Sarah, Tarique, Mohammed (Eds.) pp-161-202, Published on July-1, 2021 Elsevier.

24.  Haque S, Mamatha J & Patra CR*. Potential Application of Silver Nanocomposites for Antimicrobial Activity. In: Biomedical Composites:Perspectives and Applications. Edited by Md Saquib Hasnain and Amit Kumar Nayak-Springer, Online publication: March 2021,Page: 93-131.

25.  Roy A, Basuthakur P, Haque S & Patra CR. Silver-Based Nanoparticles for Antibacterial Activity: Recent Development and Mechanistic Approaches. In: Microbial Interactions at Nano-Bio Interfaces (https://doi.org/10.1002/9781119617181.ch8). Edited by R. Navanietha Krishnaraj-Wiley,(In Press).

26.  Nimushakavi S#, Haque S#, Kotcherlakota R* & Patra CR*. Biomedical Applications of Carbon Nanotubes: Recent Development and Future Challenges. In: Nanoengineering of Biomaterials (https://doi.org/10.1002/9783527832095.ch29). Edited by Jana & Jana-Wiley-VCH Verlag GmbH & Co. KGaA, Germany (in Press).

27.  Haque S, Tripathy S & Patra CR*. Graphene based Nanomaterials for ROS Mediated Cancer Therapeutic. In: Handbook of Oxidative Stress in Cancer: Therapeutic Aspects, Springer (in Press).

28.  Haque S, & Patra CR*. Metal Nanoparticles for Neurodegenerative Diseases. In Nanomedical Drug Delivery for Neurodegenerative Disease, Page-183-206 (2022). Edited by Yadav-Academic press (Elsevier).

29.  Basuthakur P & Patra CR*. Role of angiogenic inorganic nanomaterials in dentistry applications. In Nanotechnology for Dentistry Applications (Published on December 2021). Edited by AK Shukla-IOP Publisher.

30.  Roy A & Patra CR*. Inorganic Nanosystems for cancer theranostics. In Inorganic Nanosystems. Edited by Md Saquib Hasnain, Amit Kumar Nayak, Tejraj M. Aminabhavi-Elsevier (Under Review).

31.  Tripathy S, Haque S and Patra CR*. Metal based Drug Delivery Systems for Cancer Immunotherapy. In: Advanced and Modern Approaches for Drug Delivery” by Elsevier. Edited by Nayak AK, Hasnain M.S and Laha B, Elsevier (Under Review).

32.  Londhe S, Haque S & Patra CR*. Gold and Silver Nanoparticles: Potential Cancer Theranostics applications. In: Gold And Silver Nanoparticles: Synthesis And Applications .-Elsevier (Under Review)

33.  Haque S & Patra CR*. Casein-based nanosystems for therapeutic applications. In Polymeric Nanosystems. Edited by Md Saquib Hasnain, Amit Kumar Nayak, Tejraj M. Aminabhavi-Elsevier (Used by Production Manager).